相似化合物
1363381-91-2 1147557-97-8 1237542-04-9欧盟法规
C&L通报上下游产品
CAS号1239320-10-5 tert-butyl 5,5-... | CAS号1147557-97-8 6-羟基-2-氮杂螺[3.3]... | CAS号934664-41-2 3-亚甲基吖丁啶-1-羧酸叔丁酯 | CAS号1147557-97-8 6-羟基-2-氮杂螺[3.3]...合成工艺路线路线简述
- 合成目标产物 Tert-Butyl 6-Oxo-2-Azaspiro[3.3]Heptane-2-Carboxylate 主要起始原料 Tert-Butyl 5,5-Dichloro-6-Oxo-2-Azaspiro[3.3]Heptane-2-Carboxylate
- (文献来源)合成步骤主要原料 Tert-Butyl 5,5-Dichloro-6-Oxo-2-Azaspiro[3.3]Heptane-2-Carboxylate
海关参考信息
- 2905122000-异丙醇
2905143000-叔丁醇
2912110000-甲醛
2912120000-乙醛 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:US-2022363662-A1
优先权日:2021-04-20
标题 :Compounds as lxr agonists
发明人:PUJALA BRAHMAM; SATHE BALAJI DASHRATH; DANODIA ABHINANDAN; GUPTA ASHU; SONI SANJEEV; KUMAR VIVEK; ANSARI AMANTULLAH; KHAN FARHA; SARKAR ARINDAM; PAYGHAN PAVAN V
权利人:INTEGRAL BIOSCIENCES PRIVATED LTD
摘要:The present invention generally discloses compounds having LXR (the liver X receptor) agonistic activity, to the use of such compounds in the treatment of various disorders such as proliferative disorders, Alzheimer's disease, inflammatory diseases, and diseases characterized by defects in cholesterol and lipid metabolism. Specifically, the present invention discloses compound of formula (IA) which exhibit LXR agonist activity, specifically to LXRβ. The invention also discloses method of synthesis of said compounds, method of using said compounds, pharmaceutical compositions comprising said compounds and method of using thereof.
专利号:CN-102442934-A
优先权日:2011-12-13
标题 :Synthesis method of tert-butyl 6-oxo-2-azaspiro[3,3]heptane-2-carboxylate
专利号:CN-120136757-A
优先权日:2023-12-04
标题:Synthesis method of 6-hydroxy-2-azaspiro [3.3] heptane compounds